Literature DB >> 12508391

Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans.

Jim C Oates1, Marc C Levesque, Maurine R Hobbs, Erica Grace Smith, Ivan D Molano, Grier P Page, Bruce S Hill, J Brice Weinberg, Glinda S Cooper, Gary S Gilkeson.   

Abstract

OBJECTIVE: Systemic lupus erythematosus (SLE) is an autoimmune disease in which morbidity and mortality are higher in African-Americans. The etiology of this racial disparity is unknown. A genetic predisposition to enhanced nitric oxide (NO) production may predispose African-Americans to develop SLE and may increase disease severity. We have demonstrated a correlation between NO production and disease activity in SLE. Two polymorphisms in the inducible NO synthase (NOS2) promoter region (G-954C and CCTTT microsatellite repeat polymorphisms) are associated with improved outcome in some African patients with malaria. This study was designed to determine if these polymorphisms are associated with SLE.
METHODS: We assessed the frequency of both the G-954C and CCTTT microsatellite repeat NOS2 promoter polymorphisms in a cohort of patients with SLE and age, sex, and race matched controls in North Carolina and South Carolina.
RESULTS: Both polymorphisms were more frequent among African-American female SLE patients when compared with controls (p = 0.04 for the G-954C polymorphism and p = 0.03 for the CCTTT-8 repeat polymorphism). Further, the G-954C and CCTTT-8 repeat polymorphisms were in linkage disequilibrium (D cent = 0.89, p = 0.0001) among African-American female SLE patients.
CONCLUSION: Altered genetic control of NOS2 transcription may be a risk factor for SLE among African-American females. The extent of linkage disequilibrium between the G-954C and CCTTT-8 repeat NOS2 promoter polymorphisms suggests that they were co-inherited.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12508391

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

1.  Ocular manifestation of systemic lupus erythematosus.

Authors:  Rawhya R El-Shereef; Ahmad Shawkat Mohamed; Lamiaa Hamdy
Journal:  Rheumatol Int       Date:  2011-12-28       Impact factor: 2.631

Review 2.  The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus.

Authors:  Jim C Oates; Gary S Gilkeson
Journal:  Clin Immunol       Date:  2006-07-24       Impact factor: 3.969

Review 3.  The biology of reactive intermediates in systemic lupus erythematosus.

Authors:  Jim C Oates
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

4.  An Intervention to Reduce Psychosocial and Biological Indicators of Stress in African American Lupus Patients: The Balancing Lupus Experiences with Stress Strategies Study.

Authors:  Edith M Williams; Megan Penfield; Diane Kamen; James C Oates
Journal:  Open J Prev Med       Date:  2014-01

5.  Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis.

Authors:  Jim C Oates; Stephanie R Shaftman; Sally E Self; Gary S Gilkeson
Journal:  Arthritis Rheum       Date:  2008-01

6.  Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus.

Authors:  Henda Bouali; Paul Nietert; Tamara M Nowling; Janardan Pandey; Mary Anne Dooley; Glinda Cooper; John Harley; Diane L Kamen; Jim Oates; Gary Gilkeson
Journal:  J Rheumatol       Date:  2007-09-15       Impact factor: 4.666

7.  Chromosome 17p12-q11 harbors susceptibility loci for systemic lupus erythematosus.

Authors:  Cecilia M Johansson; Renata Zunec; Mercedes A García; Hugo R Scherbarth; Guillermo A Tate; Sergio Paira; Sandra M Navarro; Carlos E Perandones; Susana Gamron; Alejandro Alvarellos; Cesar E Graf; Jorge Manni; Guillermo A Berbotto; Simon A Palatnik; Luis J Catoggio; Cristina G Battagliotti; Gian Domenico Sebastiani; Sergio Migliaresi; Mauro Galeazzi; Bernardo A Pons-Estel; Marta E Alarcón-Riquelme
Journal:  Hum Genet       Date:  2004-07-01       Impact factor: 4.132

8.  Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes.

Authors:  Marc C Levesque; Maurine R Hobbs; Charles W O'Loughlin; Jennifer A Chancellor; Youwei Chen; Ariana N Tkachuk; Jennifer Booth; Kistie B Patch; Sallie Allgood; Ann R Pole; Carolyn A Fernandez; Esther D Mwaikambo; Theonest K Mutabingwa; Michal Fried; Bess Sorensen; Patrick E Duffy; Donald L Granger; Nicholas M Anstey; J Brice Weinberg
Journal:  Hum Genet       Date:  2009-10-27       Impact factor: 4.132

Review 9.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

10.  Analysis of Molecular Mechanism of Erxian Decoction in Treating Osteoporosis Based on Formula Optimization Model.

Authors:  Lang Yang; Liuyi Fan; Kexin Wang; Yupeng Chen; Lan Liang; Xuemei Qin; Aiping Lu; Peng Cao; Bin Yu; Daogang Guan; Junxiang Peng
Journal:  Oxid Med Cell Longev       Date:  2021-06-18       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.